Indeed, the fact that EphA2 loss of function in the primary tumor within the mammary microenvironment impairs proliferation and/or survival29, 40 but has no effect on tumor cell proliferation in the bone microenvironment, highlights the importance of systematic testing in multiple models that reflect the spectrum of tumor progression in relevant microenvironments. Here, EPHA2 is linked to neoplasm.